NeoMed Innovation V

NeoMed Innovation V is a healthcare-focused venture capital fund managed by NeoMed Management rather than an operating biotech, pharma, or healthcare products company. The fund was launched as a 2013 vintage vehicle and invested in pharmaceutical, biotechnology, healthcare device, and supply companies, with disclosed portfolio activity including companies such as Sonendo, X4 Pharmaceuticals, Arsanis, Oxular, Immunocore, Calliditas Therapeutics France, and TopiVert. Available secondary sources indicate that the fund has been described as liquidated, suggesting it is no longer an active investment vehicle. Because it is an investment fund and not a therapeutic developer, it does not have a drug pipeline, platform, modalities, targets, or indications of its own.